GSK3 function in the brain during development, neuronal plasticity, and neurodegeneration

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Salcedo Tello, Pamela ^a   Ortiz Matamoros, Abril ^a   Arias, Clorinda ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CADHERIN; GLYCOGEN SYNTHASE KINASE 3; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 2; NEUREXIN; NEUROLEPTIC AGENT; NEUROLIGIN; WNT7A PROTEIN;

ALZHEIMER DISEASE; AUTISM; BIPOLAR DISORDER; BRAIN DEVELOPMENT; COGNITION; CYTOSKELETON; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; HUMAN; LIFESPAN; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROPSYCHIATRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 79959223383     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/189728     Document Type: Review

References (151)

1. Stambolic V., Ruel L., Woodgett J. R., Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells Current Biology 1996 6 12 1664 1668 (Pubitemid 27050234)
2. Frame S., Cohen P., GSK3 takes centre stage more than 20 years after its discovery Biochemical Journal 2001 359 1 1 16 (Pubitemid 32939202)
3. Embi N., Rylatt D. B., Cohen P., Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase European Journal of Biochemistry 1980 107 2 519 527
4. Woodgett J. R., Molecular cloning and expression of glycogen synthase kinase-3/Factor A EMBO Journal 1990 9 8 2431 2438
5. Plyte S. E., Hughes K., Nikolakaki E., Pulverer B. J., Woodgett J. R., Glycogen synthase kinase-3: functions in oncogenesis and development Biochimica et Biophysica Acta 1992 1114 2-3 147 162 (Pubitemid 23008367)
6. Mukai F., Ishiguro K., Sano Y., Fujita S. C., Aternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3 Journal of Neurochemistry 2002 81 5 1073 1083 (Pubitemid 34809290)
7. Ali A., Hoeflich K. P., Woodgett J. R., Glycogen synthase kinase-3: properties, functions, and regulation Chemical Reviews 2001 101 8 2527 2540 (Pubitemid 35373033)
8. Cohen P., Frame S., The renaissance of GSK3 Nature Reviews Molecular Cell Biology 2001 2 10 769 776 (Pubitemid 33679839)
9. Woodgett J. R., Judging a protein by more than its name: GSK-3 Science's STKE 2001 2001 100 RE12
10. Cohen P., Goedert M., GSK3 inhibitors: development and therapeutic potential Nature Reviews Drug Discovery 2004 3 6 479 487 (Pubitemid 38807530)
11. Hughes K., Nikolakaki E., Plyte S. E., Totty N. F., Woodgett J. R., Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation EMBO Journal 1993 12 2 803 808 (Pubitemid 23073729)
12. Wang Q. M., Fiol C. J., DePaoli-Roach A. A., Roach P. J., Glycogen synthase kinase-3 is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation Journal of Biological Chemistry 1994 269 20 14566 14574
13. Lochhead P. A., Kinstrie R., Sibbet G., Rawjee T., Morrice N., Cleghone V., A chaperone-dependent GSK3 transitional intermediate mediates activation-loop autophosphorylation Molecular Cell 2006 24 4 627 633 (Pubitemid 350284229)
14. Hartigan J. A., Xiong W. C., Johnson G. V. W., Glycogen synthase kinase 3 is tyrosine phosphorylated by PYK2 Biochemical and Biophysical Research Communications 2001 284 2 485 489 (Pubitemid 32918003)
15. Cole A., Frame S., Cohen P., Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event Biochemical Journal 2004 377 1 249 255 (Pubitemid 38114452)
16. Jope R. S., Johnson G. V. W., The glamour and gloom of glycogen synthase kinase-3 Trends in Biochemical Sciences 2004 29 2 95 102 (Pubitemid 38186580)
17. Thornton T. M., Pedraza-Alva G., Deng B., Wood C. D., Aronshtam A., Clements J. L., Sabio G., Davis R. J., Matthews D. E., Doble B., Rincon M., Phosphorylation by p38 MAPK as an alternative pathway for GSK3 inactivation Science 2008 320 5876 667 670 (Pubitemid 351928349)
18. Cadigan K. M., Liu Y. I., Wnt signaling: complexity at the surface Journal of Cell Science 2006 119 3 395 402
19. Goi-Oliver P., Lucas J. J., Avila J., Hernndez F., N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation Journal of Biological Chemistry 2007 282 31 22406 22413 (Pubitemid 47267365)
20. Bijur G. N., Jope R. S., Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria Neuroreport 2003 14 18 2415 2419
21. Sugden P. H., Fuller S. J., Weiss S. C., Clerk A., Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis British Journal of Pharmacology 2008 153 1 S137 S153
22. Hernndez F., de Barreda E. G., Fuster-Matanzo A., Goi-Oliver P., Lucas J. J., Avila J., The role of GSK3 in Alzheimer disease Brain Research Bulletin 2009 80 4-5 248 250
23. Yao H. B., Shaw P. C., Wong C. C., Wan D. C. C., Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain Journal of Chemical Neuroanatomy 2002 23 4 291 297
24. Giese K. P., GSK-3: a key player in neurodegeneration and memory IUBMB Life 2009 61 5 516 521
25. Lee S. J., Chung Y. H., Joo K. M., Lim H. C., Jeon G. S., Kim D., Lee W. B., Kim Y. S., Cha C. I., Age-related changes in glycogen synthase kinase 3 (GSK3 ) immunoreactivity in the central nervous system of rats Neuroscience Letters 2006 409 2 134 139 (Pubitemid 44634967)
26. Takahashi M., Tomizawa K., Kato R., Sato K., Uchida T., Fujita S. C., Imahori K., Localization and developmental changes of protein kinase I/glycogen synthase kinase-3 in rat brain Journal of Neurochemistry 1994 63 1 245 255 (Pubitemid 24184925)
27. Takahashi M., Tomizawa K., Ishiguro K., Distribution of tau protein kinase I/glycogen synthase kinase-3, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain Brain Research 2000 857 1-2 193 206 (Pubitemid 30107806)
28. Leroy K., Brion J. P., Developmental expression and localization of glycogen synthase kinase-3 in rat brain Journal of Chemical Neuroanatomy 1999 16 4 279 293 (Pubitemid 29296952)
29. Soutar M. P.M., Kim W. -Y., Williamson R., Peggie M., Hastie C. J., McLauchlan H., Snider W. D., Gordon-Weeks P. R., Sutherland C., Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain Journal of Neurochemistry 2010 115 4 974 983
30. Goold R. G., Gordon-Weeks P. R., Glycogen synthase kinase 3 and the regulation of axon growth Biochemical Society Transactions 2004 32 5 809 811 (Pubitemid 39524385)
31. Trivedi N., Marsh P., Goold R. G., Wood-Kaczmar A., Gordon-Weeks P. R., Glycogen synthase kinase-3 phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons Journal of Cell Science 2005 118 5 993 1005 (Pubitemid 40484889)
32. Castao Z., Gordon-Weeks P. R., Kypta R. M., The neuron-specific isoform of glycogen synthase kinase-3 is required for axon growth Journal of Neurochemistry 2010 113 1 117 130
33. O'Brien W. T., Harper A. D., Jov F., Woodgett J. R., Maretto S., Piccolo S., Klein P. S., Glycogen synthase kinase-3 haploinsufficiency mimics the behavioral and molecular effects of lithium Journal of Neuroscience 2004 24 30 6791 6798 (Pubitemid 38993901)
34. Beaulieu J. M., Zhang X., Rodriguiz R. M., Sotnikova T. D., Cools M. J., Wetsel W. C., Gainetdinov R. R., Caron M. G., Role of GSK3 in behavioral abnormalities induced by serotonin deficiency Proceedings of the National Academy of Sciences of the United States of America 2008 105 4 1333 1338 (Pubitemid 351397053)
35. Kimura T., Yamashita S., Nakao S., Park J. M., Murayama M., Mizoroki T., Yoshiike Y., Sahara N., Takashima A., GSK-3 is required for memory reconsolidation in adult brain PLoS One 2008 3 10
36. MacAulay K., Doble B. W., Patel S., Hansotia T., Sinclair E. M., Drucker D. J., Nagy A., Woodgett J. R., Glycogen synthase kinase 3 -specific regulation of murine hepatic glycogen metabolism Cell Metabolism 2007 6 4 329 337 (Pubitemid 47450185)
37. Kaidanovich-Beilin O., Lipina T. V., Takao K., Van Eede M., Hattori S., Lalibert C., Khan M., Okamoto K., Chambers J. W., Fletcher P. J., MacAulay K., Doble B. W., Henkelman M., Miyakawa T., Roder J., Woodgett J. R., Abnormalities in brain structure and behavior in GSK-3alpha mutant mice Molecular Brain 2009 2 1, article no. 35
38. Prickaerts J., Moechars D., Cryns K., Lenaerts I., Van Craenendonck H., Goris I., Daneels G., Bouwknecht J. A., Steckler T., Transgenic mice overexpressing glycogen synthase kinase 3 : a putative model of hyperactivity and mania Journal of Neuroscience 2006 26 35 9022 9029 (Pubitemid 44319393)
39. de Barreda E. G., Prez M., Gmez-Ramos P., de Cristobal J., Martn-Maestro P., Morn A., Dawson H. N., Vitek M. P., Lucas J. J., Hernndez F., Avila J., Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits Neurobiology of Disease 2010 37 3 622 629
40. Zhou F. Q., Snider W. D., GSK-3 and microtubule assembly in axons Science 2005 308 5719 211 214
41. Beaulieu J. M., Gainetdinov R. R., Caron M. G., Akt/GSK3 signaling in the action of psychotropic drugs Annual Review of Pharmacology and Toxicology 2009 49 327 347
42. Jope R. S., Roh M. S., Glycogen synthase kinase-3 (GSK3) in psychiatric disease and therapeutic interventions Current Drug Targets 2006 7 11 1421 1434 (Pubitemid 44718302)
43. Mazanetz M. P., Fischer P. M., Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases Nature Reviews Drug Discovery 2007 6 6 464 479 (Pubitemid 47064569)
44. Lovestone S., Killick R., Di Forti M., Murray R., Schizophrenia as a GSK-3 dysregulation disorder Trends in Neurosciences 2007 30 4 142 149 (Pubitemid 46482684)
45. Rayasam G. V., Tulasi V. K., Sodhi R., Davis J. A., Ray A., Glycogen synthase kinase 3: more than a namesake British Journal of Pharmacology 2009 156 6 885 898
46. Hernndez F., Gmez de Barreda E., Fuster-Matanzo A., Lucas J. J., Avila J., GSK3: a possible link between beta amyloid peptide and tau protein Experimental Neurology 2010 223 2 322 325
47. Avila J., Wandosell F., Hernndez F., Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors Expert Review of Neurotherapeutics 2010 10 5 703 710
48. Rodgers E. E., Theibert A. B., Functions of PI 3-kinase in development of the nervous system International Journal of Developmental Neuroscience 2002 20 35 187 197
49. Castellano E., Downward J., Role of RAS in the regulation of PI 3-kinase Current Topics in Microbiology and Immunology 2010 346 143 169
50. Chen J., Chang S. P., Tang S. J., Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation Journal of Biological Chemistry 2006 281 17 11910 11916 (Pubitemid 43855453)
51. Speese S. D., Budnik V., Wnts: up-and-coming at the synapse Trends in Neurosciences 2007 30 6 268 275 (Pubitemid 46805177)
52. Faras G. G., Godoy J. A., Cerpa W., Varela-Nallar L., Inestrosa N. C., Wnt signaling modulates pre- and postsynaptic maturation: therapeutic considerations Developmental Dynamics 2010 239 1 94 101
53. Hur E.-M., Zhou F.-Q., GSK3 signalling in neural development Nature Reviews Neuroscience 2010 11 8 539 551
54. De Ferrariand G. V., Inestrosa N. C., Wnt signaling function in Alzheimer's disease Brain Research Reviews 2000 33 1 1 12
55. Wehrli M., Dougan S. T., Caldwell K., O'Keefe L., Schwartz S., Valzel-Ohayon D., Schejter E., Tomlinson A., DiNardo S., Arrow encodes an LDL-receptor-related protein essential for Wingless signalling Nature 2000 407 6803 527 530
56. Ikeda S., Kishida S., Yamamoto H., Murai H., Koyama S., Kikuchi A., Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3 and -catenin and promotes GSK-3 -dependent phosphorylation of -catenin EMBO Journal 1998 17 5 1371 1384 (Pubitemid 28105516)
57. Van Noort M., Clevers H., TCF transcription factors, mediators of Wnt-signaling in development and cancer Developmental Biology 2002 244 1 1 8 (Pubitemid 34271136)
58. Taelman V. F., Dobrowolski R., Plouhinec J. -L., Fuentealba L. C., Vorwald P. P., Gumper I., Sabatini D. D., De Robertis E. M., Wnt signaling requires sequestration of Glycogen Synthase Kinase 3 inside multivesicular endosomes Cell 2010 143 7 1136 1148
59. Kawano Y., Kypta R., Secreted antagonists of the Wnt signalling pathway Journal of Cell Science 2003 116 13 2627 2634 (Pubitemid 36857216)
60. Mao Y., Ge X., Frank C. L., Madison J. M., Koehler A. N., Doud M. K., Tassa C., Berry E. M., Soda T., Singh K. K., Biechele T., Petryshen T. L., Moon R. T., Haggarty S. J., Tsai LI. H., Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3 / -catenin signaling Cell 2009 136 6 1017 1031
61. Beaulieu J. M., Sotnikova T. D., Marion S., Lefkowitz R. J., Gainetdinov R. R., Caron M. G., An Akt/ -arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior Cell 2005 122 2 261 273 (Pubitemid 41032989)
62. Mei L., Xiong W. C., Neuregulin 1 in neural development, synaptic plasticity and schizophrenia Nature Reviews Neuroscience 2008 9 6 437 452 (Pubitemid 351704944)
63. Mckenzie G., Ward G., Stallwood Y., Briend E., Papadia S., Lennard A., Turner M., Champion B., Hardingham G. E., Cellular notch responsiveness is defined by phosphoinositide 3-kinase-dependent-signals BMC Cell Biology 2006 7, article no. 10
64. Wang Y., Chan S. L., Miele L., Yao P. J., Mackes J., Ingram D. K., Mattson M. P., Furukawa K., Involvement of Notch signaling in hippocampal synaptic plasticity Proceedings of the National Academy of Sciences of the United States of America 2004 101 25 9458 9462 (Pubitemid 38812896)
65. Gordon-Weeks P. R., Microtubules and growth cone function Journal of Neurobiology 2004 58 1 70 83 (Pubitemid 37543339)
66. Lucas F. R., Goold R. G., Gordon-Weeks P. R., Salinas P. C., Inhibition of GSK-3 leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium Journal of Cell Science 1998 111 10 1351 1361 (Pubitemid 28274387)
67. Goold R. G., Owen R., Gordon-Weeks P. R., Glycogen synthase kinase 3 phosphorylation of microtubule-associated protein 1B regulates the stability of microtubules in growth cones Journal of Cell Science 1999 112 19 3373 3384 (Pubitemid 29507217)
68. Goold R. G., Gordon-Weeks P. R., The MAP kinase pathway is upstream of the activation of GSK3 that enables it to phosphorylate MAP1B and contributes to the stimulation of axon growth Molecular and Cellular Neuroscience 2005 28 3 524 534 (Pubitemid 40311855)
69. Gonzlez-Billault C., Del Ro J. A., Urea J. M., Jimnez-Mateos E. M., Barallobre M. J., Pascual M., Pujadas L., Sim S., La Torre A., Gavin R., Wandosell F., Soriano E., vila J., A role of MAP1B in reelin-dependent neuronal migration Cerebral Cortex 2005 15 8 1134 1145 (Pubitemid 41373606)
70. Kim W. Y., Zhou F. Q., Zhou J., Yokota Y., Wang Y. M., Yoshimura T., Kaibuchi K., Woodgett J., Anton E. S., Snider W., Essential roles for GSK-3s and GSK-3-primed substrates in neurotrophin-induced and hippocampal axon growth Neuron 2006 52 6 981 996 (Pubitemid 44909402)
71. Conde C., Cceres A., Microtubule assembly, organization and dynamics in axons and dendrites Nature Reviews Neuroscience 2009 10 5 319 332
72. Geraldo S., Gordon-Weeks P. R., Cytoskeletal dynamics in growth-cone steering Journal of Cell Science 2009 122 20 3595 3604
73. Eickholt B. J., Walsh F. S., Doherty P., An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling Journal of Cell Biology 2002 157 2 211 217 (Pubitemid 34839818)
74. Shi S. H., Cheng T., Jan L. Y., Jan Y. N., APC and GSK-3 are involved in mPar3 targeting to the nascent axon and establishment of neuronal polarity Current Biology 2004 14 22 2025 2032 (Pubitemid 39547957)
75. Jiang H., Guo W., Liang X., Rao YI., Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3 and its upstream regulators Cell 2005 120 1 123 135 (Pubitemid 40094608)
76. Yoshimura T., Kawano Y., Arimura N., Kawabata S., Kikuchi A., Kaibuchi K., GSK-3 regulates phosphorylation of CRMP-2 and neuronal polarity Cell 2005 120 1 137 149 (Pubitemid 40094609)
77. Krylova O., Herreros J., Cleverley K. E., Ehler E., Henriquez J. P., Hughes S. M., Salinas P. C., WNT-3, expressed by motoneurons, regulates terminal arborization of neurotrophin-3-responsive spinal sensory neurons Neuron 2002 35 6 1043 1056 (Pubitemid 35279533)
78. Lyuksyutova A. I., Lu C. C., Milanesio N., King L. A., Guo N., Wang Y., Nathans J., Tessier-Lavigne M., Zou Y., Anterior-posterior guidance of commissural axons by Wnt-frizzled signaling Science 2003 302 5652 1984 1988 (Pubitemid 37523510)
79. Owen R., Gordon-Weeks P. R., Inhibition of glycogen synthase kinase 3 in sensory neurons in culture alters filopodia dynamics and microtubule distribution in growth cones Molecular and Cellular Neuroscience 2003 23 4 626 637 (Pubitemid 36970223)
80. Krylova O., Messenger M. J., Salinas P. C., Dishevelled-1 regulates microtubule stability: a new function mediated by glycogen synthase kinase-3 β Journal of Cell Biology 2000 151 1 83 93
81. Ahmad-Annuar A., Ciani L., Simeonidis I., Herreros J., Fredj N. B., Rosso S. B., Hall A., Brickley S., Salinas P. C., Signaling across the synapse: a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release Journal of Cell Biology 2006 174 1 127 139 (Pubitemid 43992902)
82. Endo Y., Rubin J. S., Wnt signaling and neurite outgrowth: insights and questions Cancer Science 2007 98 9 1311 1317 (Pubitemid 47241750)
83. Gao C., Chen Y. G., Dishevelled: the hub of Wnt signaling. Cellular Signalling 2010 22 5 717 727
84. Salinas P. C., Retrograde signalling at the synapse: a role for Wnt proteins Biochemical Society Transactions 2005 33 6 1295 1298 (Pubitemid 41779671)
85. Salinas P. C., Wnt factors in axonal remodelling and synaptogenesis Biochemical Society Symposium 1999 65 101 109 (Pubitemid 129541616)
86. Ciani L., Krylova O., Smalley M. J., Dale T. C., Salinas P. C., A divergent canonical WNT-signaling pathway regulates microtubule dynamics: dishevelled signals locally to stabilize microtubules Journal of Cell Biology 2004 164 2 243 253 (Pubitemid 38133944)
87. Hall A. C., Lucas F. R., Salinas P. C., Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling Cell 2000 100 5 525 535
88. Lucas F. R., Salinas P. C., WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons Developmental Biology 1997 192 1 31 44 (Pubitemid 28015644)
89. Chin L. S., Li L., Ferreira A., Kosik K. S., Greengard P., Impairment of axonal development and of synaptogenesis in hippocampal neurons of synapsin I-deficient mice Proceedings of the National Academy of Sciences of the United States of America 1995 92 20 9230 9234
90. Rosahl T. W., Spillane D., Missler M., Herz J., Selig D. K., Wolff J. R., Hammer R. E., Malenka R. C., Sudhof T. C., Essential functions of synapsins I and II in synaptic vesicle regulation Nature 1995 375 6531 488 493
91. Zhu L.-Q., Wang S.-H., Liu D., Yin Y.-Y., Tian Q., Wang X. -C., Wang Q., Chen J. -G., Wang J. -Z., Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments Journal of Neuroscience 2007 27 45 12211 12220 (Pubitemid 350085482)
92. Davis E. K., Zou Y., Ghosh A., Wnts acting through canonical and noncanonical signaling pathways exert opposite effects on hippocampal synapse formation Neural Development 2008 3 1, article no. 32
93. Plattner F., Angelo M., Giese K. P., The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation Journal of Biological Chemistry 2006 281 35 25457 25465 (Pubitemid 44401934)
94. Clayton E. L., Sue N., Smillie K. J., O'Leary T., Bache N., Cheung G., Cole A. R., Wyllie D. J., Sutherland C., Robinson P. J., Cousin M. A., Dynamin i phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles Nature Neuroscience 2010 13 7 845 851
95. Pittenger C., Kandel E., A genetic switch for long-term memory Comptes Rendus de l'Academie des Sciences-Serie III 1998 321 2-3 91 96 (Pubitemid 28138153)
96. Huang E. P., Synaptic plasticity: going through phases with LTP Current Biology 1998 8 10 R350 R352
97. Stanton P. K., LTD, LTP, and the sliding threshold for long-term synaptic plasticity Hippocampus 1996 6 1 35 42 (Pubitemid 26153050)
98. Lisman J., Long-term potentiation: outstanding questions and attempted synthesis Philosophical Transactions of the Royal Society B 2003 358 1432 829 842 (Pubitemid 36536715)
99. Malenka R. C., Bear M. F., LTP and LTD: an embarrassment of riches Neuron 2004 44 1 5 21 (Pubitemid 39348827)
100. Hooper C., Markevich V., Plattner F., Killick R., Schofield E., Engel T., Hernandez F., Anderton B., Rosenblum K., Bliss T., Cooke S. F., Avila J., Lucas J. J., Giese K. P., Stephenson J., Lovestone S., Glycogen synthase kinase-3 inhibition is integral to long-term potentiation European Journal of Neuroscience 2007 25 1 81 86 (Pubitemid 46096224)
101. Peineau S., Taghibiglou C., Bradley C., Wong T. P., Liu L., Lu J., Lo E., Wu D., Saule E., Bouschet T., Matthews P., Isaac J. T. R., Bortolotto Z., Wang YU. T., Collingridge G. L., LTP inhibits LTD in the hippocampus via regulation of GSK3 Neuron 2007 53 5 703 717 (Pubitemid 46283369)
102. Cai F., Wang F., Lin F. K., Liu C., Ma LI. Q., Liu J., Wu W. N., Wang W., Wang J. H., Chen J. G., Redox modulation of long-term potentiation in the hippocampus via regulation of the glycogen synthase kinase-3 pathway Free Radical Biology and Medicine 2008 45 7 964 970
103. Nichols R. A., Chilcote T. J., Czernik A. J., Greengard P., Synapsin I regulates glutamate release from rat brain synaptosomes Journal of Neurochemistry 1992 58 2 783 785
104. Greengard P., Valtorta F., Czernik A. J., Benfenati F., Synaptic vesicle phosphoproteins and regulation of synaptic function Science 1993 259 5096 780 785 (Pubitemid 23066304)
105. Pieribone V. A., Shupliakov O., Brodin L., Hilfiker-Rothenfluh S., Czernik A. J., Greengard P., Distinct pools of synaptic vesicles in neurotransmitter release Nature 1995 375 6531 493 497
106. Hilfiker S., Pieribone V. A., Czernik A. J., Kao H.-T., Augustine G. J., Greengard P., Synapsins as regulators of neurotransmitter release Philosophical Transactions of the Royal Society B 1999 354 1381 269 279 (Pubitemid 29365600)
107. Chi P., Greengard P., Ryan T. A., Synapsin dispersion and reclustering during synaptic activity Nature Neuroscience 2001 4 12 1187 1193 (Pubitemid 33135623)
108. Bloom O., Evergren E., Tomilin N., Kjaerulff O., Lw P., Brodin L., Pieribone V. A., Greengard P., Shupliakov O., Colocalization of synapsin and actin during synaptic vesicle recycling Journal of Cell Biology 2003 161 4 737 747 (Pubitemid 36648757)
109. Melloni R. H. Jr., Hemmendinger L. M., Hamos J. E., DeGennaro L. J., Synapsin I gene expression in the adult rat brain with comparative analysis of mRNA and protein in the hippocampus Journal of Comparative Neurology 1993 327 4 507 520 (Pubitemid 23033647)
110. Sato K., Morimoto K., Suemaru S., Sato T., Yamada N., Increased synapsin I immunoreactivity during long-term potentiation in rat hippocampus Brain Research 2000 872 1-2 219 222 (Pubitemid 30618908)
111. Bortolotto Z. A., Collingridge G. L., A role for protein kinase C in a form of metaplasticity that regulates the induction of long-term potentiation at CA1 synapses of the adult rat hippocampus European Journal of Neuroscience 2000 12 11 4055 4062
112. Sanna P. P., Cammalleri M., Berton F., Simpson C., Lutjens R., Bloom F. E., Francesconi W., Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of longterm potentiation in the hippocampal CA1 region Journal of Neuroscience 2002 22 9 3359 3365 (Pubitemid 37465741)
113. Opazo P., Watabe A. M., Grant S. G.N., O'Dell T. J., Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms Journal of Neuroscience 2003 23 9 3679 3688 (Pubitemid 36958476)
114. Gardoni F., Caputi A., Cimino M., Pastorino L., Cattabeni F., Di Luca M., Calcium/calmodulin-dependent protein kinase II is associated with NR2A/B subunits of NMDA receptor in postsynaptic densities Journal of Neurochemistry 1998 71 4 1733 1741 (Pubitemid 28443048)
115. Teter B., Ashford J. W., Neuroplasticity in Alzheimer's disease Journal of Neuroscience Research 2002 70 3 402 437 (Pubitemid 35222379)
116. Beattie E. C., Carroll R. C., Yu X., Morishita W., Yasuda H., Von Zastrow M., Malenka R. C., Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD Nature Neuroscience 2000 3 12 1291 1300
117. Collingridge G. L., Isaac J. T. R., Yu T. W., Receptor trafficking and synaptic plasticity Nature Reviews Neuroscience 2004 5 12 952 962 (Pubitemid 39593358)
118. Lisman J., A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory Proceedings of the National Academy of Sciences of the United States of America 1989 86 23 9574 9578 (Pubitemid 20010470)
119. Purro S. A., Ciani L., Hoyos-Flight M., Stamatakou E., Siomou E., Salinas P. C., Wnt regulates axon behavior through changes in microtubule growth directionality: a new role for adenomatous polyposis coli Journal of Neuroscience 2008 28 34 8644 8654
120. Hernndez F., Borrell J., Guaza C., Avila J., Lucas J. J., Spatial learning deficit in transgenic mice that conditionally over-express GSK-3 in the brain but do not form tau filaments Journal of Neurochemistry 2002 83 6 1529 1533 (Pubitemid 35477491)
121. Peineau S., Bradley C., Taghibiglou C., Doherty A., Bortolotto Z. A., Wang Y. T., Collingridge G. L., The role of GSK-3 in synaptic plasticity British Journal of Pharmacology 2008 153 supplement 1 S428 S437
122. Hooper C., Killick R., Lovestone S., The GSK3 hypothesis of Alzheimer's disease Journal of Neurochemistry 2008 104 6 1433 1439 (Pubitemid 351316776)
123. Diaz A., Mendieta L., Zenteno E., Guevara J., Limon I. D., The role of NOS in the impairment of spatial memory and damaged neurons in rats injected with amyloid beta 2535 into the temporal cortex Pharmacology Biochemistry and Behavior 2011 98 1 67 75
124. Sydow A., Van Der Jeugd A., Zheng F., Ahmed T., Balschun D., Petrova O., Drexler D., Zhou L., Rune G., Mandelkow E., D'Hooge R., Alzheimer C., Mandelkow E. -M., Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic tau mutant Journal of Neuroscience 2011 31 7 2511 2525
125. Sun X., Sato S., Murayama O., Murayama M., Park J. M., Yamaguchi H., Takashima A., Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100 Neuroscience Letters 2002 321 1-2 61 64 (Pubitemid 34185499)
126. Phiel C. J., Wilson C. A., Lee V. M. Y., Klein P. S., GSK-3 regulates production of Alzheimer's disease amyloid- peptides Nature 2003 423 6938 435 439 (Pubitemid 36626994)
127. Iqbal K., Grundke-Iqbal I., Discoveries of Tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective Journal of Alzheimer's Disease 2006 9 3 219 242 (Pubitemid 44253315)
128. Ishiguro K., Shiratsuchi A., Sato S., Omori A., Arioka M., Kobayashi S., Uchida T., Imahori K., Glycogen synthase kinase 3 is identical to tau protein kinase I generating several epitopes of paired helical filaments FEBS Letters 1993 325 3 167 172 (Pubitemid 23186470)
129. Pei J. J., Tanaka T., Tung Y. C., Braak E., Iqbal K., Grundke-Iqbal I., Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain Journal of Neuropathology and Experimental Neurology 1997 56 1 70 78 (Pubitemid 127470328)
130. Hanger D. P., Anderton B. H., Noble W., Tau phosphorylation: the therapeutic challenge for neurodegenerative disease Trends in Molecular Medicine 2009 15 3 112 119
131. Leroy A., Landrieu I., Huvent I., Spectroscopic studies of GSK3 phosphorylation of the neuronal Tau protein and its interaction with the N-terminal domain of apolipoprotein E Journal of Biological Chemistry 2010 285 43 33435 33444
132. Lucas J. J., Hernndez F., Gmez-Ramos P., Morn M. A., Hen R., Avila J., Decreased nuclear -catenin, tau hyperphosphorylation and neurodegeneration in GSK-3 conditional transgenic mice EMBO Journal 2001 20 1-2 27 39 (Pubitemid 32099099)
133. Engel T., Goi-Oliver P., Lucas J. J., Avila J., Hernndez F., Chronic lithium administration to FTDP-17 tau and GSK-3 overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert Journal of Neurochemistry 2006 99 6 1445 1455 (Pubitemid 44924224)
134. Jackson G. R., Wiedau-Pazos M., Sang T. K., Wagle N., Brown C. A., Massachi S., Geschwind D. H., Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila Neuron 2002 34 4 509 519 (Pubitemid 34628749)
135. Prez M., Hernndez F., Lim F., Daz-Nido J., Avila J., Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model Journal of Alzheimer's Disease 2003 5 4 301 308 (Pubitemid 37411777)
136. Noble W., Planel E., Zehr C., Olm V., Meyerson J., Suleman F., Gaynor K., Wang L., LaFrancois J., Feinstein B., Burns M., Krishnamurthy P., Wen YI., Bhat R., Lewis J., Dickson D., Duff K., Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo Proceedings of the National Academy of Sciences of the United States of America 2005 102 19 6990 6995 (Pubitemid 40675429)
137. Seren L., Coma M., Rodrguez M., Snchez-Ferrer P., Snchez M. B., Gich I., Agull J. M., Prez M., Avila J., Guardia-Laguarta C., Clarimn J., Lle A., Gmez-Isla T., A novel GSK-3 inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo Neurobiology of Disease 2009 35 3 359 367
138. Yamaguchi H., Ishiguro K., Uchida T., Takashima A., Lemere C. A., Imahori K., Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 and cyclin-dependent kinase 5, a component of TPK II Acta Neuropathologica 1996 92 3 232 241 (Pubitemid 26278953)
139. Pei J. J., Braak E., Braak H., Grundke-Iqbal I., Iqbal K., Winblad B., Cowburn R. F., Distribution of active glycogen synthase kinase 3 (GSK-3 ) in brains staged for Alzheimer disease neurofibrillary changes Journal of Neuropathology and Experimental Neurology 1999 58 9 1010 1019 (Pubitemid 29441929)
140. Mateo I., Infante J., Llorca J., Rodrguez E., Berciano J., Combarros O., Association between glycogen synthase kinase-3 genetic polymorphism and late-onset Alzheimer's disease Dementia and Geriatric Cognitive Disorders 2006 21 4 228 232
141. Schaffer B. A. J., Bertram L., Miller B. L., Mullin K., Weintraub S., Johnson N., Bigio E. H., Mesulam M., Wiedau-Pazos M., Jackson G. R., Cummings J. L., Cantor R. M., Levey A. I., Tanzi R. E., Geschwind D. H., Association of GSK3B with Alzheimer disease and frontotemporal dementia Archives of Neurology 2008 65 10 1368 1374
142. Su Y., Ryder J., Li B., Wu X., Fox N., Solenberg P., Brune K., Paul S., Zhou Y., Liu F., Ni B., Lithium, a common drug for bipolar disorder treatment, regulates amyloid- precursor protein processing Biochemistry 2004 43 22 6899 6908 (Pubitemid 38720508)
143. Takashima A., Noguchi K., Michel G., Mercken M., Hoshi M., Ishiguro K., Imahori K., Exposure of rat hippocampal neurons to amyloid peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 β Neuroscience Letters 1996 203 1 33 36
144. Townsend M., Mehta T., Selkoe D. J., Soluble A inhibits specific signal transduction cascades common to the insulin receptor pathway Journal of Biological Chemistry 2007 282 46 33305 33312 (Pubitemid 350159548)
145. Magdesian M. H., Carvalho M. M. V. F., Mendes F. A., Saraiva L. M., Juliano M. A., Juliano L., Garcia-Abreu J., Ferreira S. T., Amyloid- binds to the extracellular cysteine-rich domain of frizzled and inhibits Wnt/ -catenin signaling Journal of Biological Chemistry 2008 283 14 9359 9368
146. De Ferrari G. V., Papassotiropoulos A., Biechele T., De-Vrieze F. W., Avila M. E., Major M. B., Myers A., Sez K., Henrquez J. P., Zhao A., Axel Wollmer M., Nitsch R. M., Hock C., Morris C. M., Hardy J., Moon R. T., Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease Proceedings of the National Academy of
147. Caruso A., Motolese M., Iacovelli L., Caraci F., Copani A., Nicoletti F., Terstappen G. C., Gaviraghi G., Caricasole A., Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells Journal of Neurochemistry 2006 98 2 364 371 (Pubitemid 44133142)
148. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D., Apolipoprotein E: high-avidity binding to -amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 1993 90 5 1977 1981 (Pubitemid 23069980)
149. Cedazo-Mnguez A., Popescu B. O., Blanco-Milln J. M., Akterin S., Pei J. J., Winblad B., Cowburn R. F., Apolipoprotein E and -amyloid (142) regulation of glycogen synthase kinase-3 Journal of Neurochemistry 2003 87 5 1152 1164 (Pubitemid 37492856)
150. Caricasole A., Copani A., Caraci F., Aronica E., Rozemuller A. J., Caruso A., Storto M., Gaviraghi G., Terstappen G. C., Nicoletti F., Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain Journal of Neuroscience 2004 24 26 6021 6027 (Pubitemid 38859398)
151. Mercado-Gmez O., Hernndez-Fonseca K., Villavicencio-Queijeiro A., Massieu L., Chimal-Monroy J., Arias C., Inhibition of Wnt and PI3K signaling modulates GSK-3 activity and induces morphological changes in cortical neurons: role of tau phosphorylation Neurochemical Research 2008 33 8 1599 1609